Author

Funmbi Babalola

Observed names: FUNMBI BABALOLA, Funmbi T. Babalola

Institutions: Western University, London Health Sciences Centre, Children's Hospital of Western Ontario

Observed institutions: Western University, University of Toronto, London Health Sciences Centre, Hospital for Sick Children, Children’s Health Research Institute, Children's Hospital of Western Ontario, Sickkids Research Institute

ORCID: 0000-0002-4460-4514

Observed ORCID: 0000-0002-4460-4514

OpenAlex ID: A5035751185

Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial

2025 · Farid H. Mahmud, Petter Bjornstad, et al. · Nature Medicine · 19

Metabolic and other morbid complications in congenital generalized lipodystrophy type 4

2024 · Gulcin Akinci, Saif Alyaarubi, et al. · American Journal of Medical Genetics Part A · 14

Bone health in young adults with type 1 diabetes and progressive eGFR decline

2024 · Funmbi Babalola, Jill Hamilton, et al. · Clinical Diabetes and Endocrinology · 3

Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4

2022 · Funmbi Babalola, Dominic Ng, et al. · Journal of Pediatric Endocrinology and Metabolism · 2

Optimizing Care for Growth and Puberty in Duchenne Muscular Dystrophy: A Survey of Clinical Practice in the OPTIMIZE DMD Consortium

2026 · Claire L. Wood, Funmbi Babalola, et al. · Muscle & Nerve · 1

Adolescents With Type 1 Diabetes Using Dapagliflozin as an Adjunct-to-Insulin: Perspectives on Experiences of Clinical Trial Participation

2025 · Samantha J. Anthony, Enid K. Selkirk, et al. · Endocrine Practice · 1

Effect of burosumab conversion on calciuria and nephrocalcinosis in children with XLH: A real-world cohort study

2025 · Guido Filler, Harry Chandrakumaran, et al. · Bone Reports · 1

Unilateral Adrenalectomy for Pediatric Cyclical Cushing Syndrome with Novel PRKAR1A Variant Associated Carney Complex

2025 · Chris J Zhang, Robert Stein, et al. · JCEM Case Reports · 1

Toward lean body weight- and ECV-based dosing of burosumab: eliminating apparent sex differences in XLH therapy

2025 · Guido Filler, Funmbi Babalola · Pediatric Nephrology · 1

397-P: eGFR Changes from Adolescence into Young Adulthood in Type 1 Diabetes: Evaluation of Novel eGFR Formulae

2022 · FUNMBI BABALOLA, ETIENNE B. SOCHETT, et al. · Diabetes · 1

Managing growth and puberty concerns in individuals with Duchenne muscular dystrophy: Updated guidance and future directions

2026 · Meilan M. Rutter, Janet L. Crane, et al. · Journal of Neuromuscular Diseases

Prolonged neonatal phosphate retention and transient hypercalcemia following antenatal Burosumab exposure: a pharmacovigilance alert

2026 · Guido Filler, Funmbi Babalola, et al. · Therapeutic Advances in Drug Safety

Frequency of diabetes team contacts in children and adolescents using insulin pumps

2022 · Funmbi T. Babalola, Michael R. Miller, et al. · Clinical Diabetology

1323-P: Frequency of Diabetes Team Contacts in Children and Adolescents Using Insulin Pumps

2020 · FUNMBI BABALOLA, MICHAEL MILLER, et al. · Diabetes

Why did I stop growing? A case of halted puberty

2020 · Funmbi Babalola, Andrea Ens · Paediatrics & Child Health

Works count: 15

Citation count: 44

H-index: 3

I10-index: 2